Ambrisentan: a review of its use in pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Ambrisentan: a review of its use in pulmonary arterial hypertension

Published:2017-04-20 Issue:6 Volume:11 Page:233-244
ISSN:1753-4666
Container-title:Therapeutic Advances in Respiratory Disease
language:en
Short-container-title:Ther Adv Respir Dis

Author:

Rivera-Lebron Belinda N.¹,Risbano Michael G.²

Affiliation:

1. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA

2. Division of Pulmonary, Allergy and Critical Care Medicine, Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute, University of Pittsburgh Medical Center, 3459 Fifth Avenue, Montefiore Hospital, NW 628, Pittsburgh, PA 15213, USA

Publisher

SAGE Publications

Subject

Pharmacology (medical),Pulmonary and Respiratory Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1753465817696040

Reference52 articles.

1. The Fifth World Symposium on Pulmonary Hypertension

2. Updated Clinical Classification of Pulmonary Hypertension

3. Overview of Current Therapeutic Approaches for Pulmonary Hypertension

4. Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension

5. Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition;Nature Reviews Drug Discovery;2024-06-18

2. Basic aspects of pathophysiology, diagnosis and treatment of patients with pulmonary arterial hypertension associated with human immunodeficiency virus infection: what has been achieved and what remains to be achieved?;Systemic Hypertension;2024-03-25

3. Classification, Diagnosis, and Medical Treatment of Pulmonary Hypertension;New Insights on Pulmonary Hypertension;2024-03-08

4. Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies;Journal of Controlled Release;2024-01

5. Allostery: The Good, the Bad, and the Ugly;Journal of Pharmacology and Experimental Therapeutics;2023-11-02